ASX - By Stock
|
SPR |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
NZJim
|
21 |
5.4K |
3 |
01/05/24 |
01/05/24 |
ASX - By Stock
|
21
|
5.4K
|
3
|
|
ASX - By Stock
|
DES |
Re:
Ann: Half Yearly Report and Accounts
|
|
NZJim
|
1 |
610 |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
1
|
610
|
2
|
|
ASX - By Stock
|
SPR |
Re:
Ann: Drilling hits visible gold over 1km deep below Never Never
|
|
NZJim
|
166 |
50K |
7 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
166
|
50K
|
7
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Strategic A$15.28M Investment from Keysight Technologies
|
|
NZJim
|
33 |
12K |
15 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
33
|
12K
|
15
|
|
ASX - By Stock
|
DES |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
NZJim
|
9 |
2.1K |
3 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
9
|
2.1K
|
3
|
|
ASX - By Stock
|
EBR |
Re:
Ann: Update on Submission of Final Module to FDA
|
|
NZJim
|
33 |
7.8K |
1 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
33
|
7.8K
|
1
|
|
ASX - By Stock
|
EBR |
Re:
Ann: Update on Submission of Final Module to FDA
|
|
NZJim
|
33 |
7.8K |
1 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
33
|
7.8K
|
1
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Encouraging Interim Clinical Trial Results
|
|
NZJim
|
13 |
5.5K |
12 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
13
|
5.5K
|
12
|
|
ASX - By Stock
|
SVY |
Re:
Ann: Compelling New Regional Porphyry Targets Identified
|
|
NZJim
|
14 |
9.0K |
5 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
14
|
9.0K
|
5
|
|
ASX - By Stock
|
EBR |
Re:
Charting
|
|
NZJim
|
219 |
56K |
3 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
219
|
56K
|
3
|
|
ASX - By Stock
|
EMV |
Re:
Ann: ASX Small & Mid Cap Conference Investor Presentation
|
|
NZJim
|
8 |
2.8K |
5 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
8
|
2.8K
|
5
|
|
ASX - By Stock
|
DES |
Re:
Ann: Fenton Drilling Update
|
|
NZJim
|
27 |
8.9K |
6 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
27
|
8.9K
|
6
|
|
ASX - By Stock
|
DES |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
NZJim
|
3 |
1.4K |
2 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
3
|
1.4K
|
2
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Significant Exploration Results Continue at EMR Prospects
|
|
NZJim
|
57 |
18K |
5 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
57
|
18K
|
5
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Significant Exploration Results Continue at EMR Prospects
|
|
NZJim
|
57 |
18K |
2 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
57
|
18K
|
2
|
|
ASX - By Stock
|
SPR |
Re:
Ann: Latest Assays Continue to Expand Never Never
|
|
NZJim
|
38 |
13K |
8 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
38
|
13K
|
8
|
|
ASX - By Stock
|
SVY |
Re:
Ann: Successful A$3.55 Million Placement
|
|
NZJim
|
58 |
21K |
3 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
58
|
21K
|
3
|
|
ASX - By Stock
|
SPR |
Re:
Ann: Change of Company Name
|
|
NZJim
|
25 |
7.1K |
6 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
25
|
7.1K
|
6
|
|
ASX - By Stock
|
EMV |
Re:
Ann: Recruitment at Royal Melbourne Hospital Commences
|
|
NZJim
|
17 |
6.1K |
7 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
17
|
6.1K
|
7
|
|
ASX - By Stock
|
SVY |
Re:
Ann: Successful A$3.55 Million Placement
|
|
NZJim
|
58 |
21K |
4 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
58
|
21K
|
4
|
|
ASX - By Stock
|
SVY |
Re:
Ann: Successful A$3.55 Million Placement
|
|
NZJim
|
58 |
21K |
3 |
28/06/23 |
28/06/23 |
ASX - By Stock
|
58
|
21K
|
3
|
|
ASX - By Stock
|
EBR |
Re:
Ann: Trading Halt
|
|
NZJim
|
26 |
6.4K |
3 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
26
|
6.4K
|
3
|
|
ASX - By Stock
|
EBR |
Re:
Ann: Trading Halt
|
|
NZJim
|
26 |
6.4K |
3 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
26
|
6.4K
|
3
|
|
ASX - By Stock
|
EBR |
Re:
Ann: Trading Halt
|
|
NZJim
|
26 |
6.4K |
6 |
22/06/23 |
22/06/23 |
ASX - By Stock
|
26
|
6.4K
|
6
|
|
ASX - By Stock
|
TAR Mining |
Re:
Argonaut Section 23 reinstated
|
|
NZJim
|
12 |
5.3K |
2 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
12
|
5.3K
|
2
|
|
ASX - By Stock
|
EMR |
Re:
Ann: Significant Exploration Results Continue at EMR Prospects
|
|
NZJim
|
56 |
21K |
4 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
56
|
21K
|
4
|
|
ASX - By Stock
|
TAR Mining |
Re:
Argonaut Section 23 reinstated
|
|
NZJim
|
12 |
5.3K |
3 |
13/05/23 |
13/05/23 |
ASX - By Stock
|
12
|
5.3K
|
3
|
|
ASX - By Stock
|
EMV |
Re:
EMvision Research Notes
|
|
NZJim
|
2.5K |
1.1M |
9 |
07/05/23 |
07/05/23 |
ASX - By Stock
|
2.5K
|
1.1M
|
9
|
|
ASX - By Stock
|
TAR |
Re:
Ann: Quarterly Activities/Appendix 5B Cash Flow Report
|
|
NZJim
|
8 |
3.8K |
2 |
28/04/23 |
28/04/23 |
ASX - By Stock
|
8
|
3.8K
|
2
|
|
ASX - By Stock
|
TAR |
Re:
Ann: Half Year Report
|
|
NZJim
|
16 |
5.8K |
4 |
16/03/23 |
16/03/23 |
ASX - By Stock
|
16
|
5.8K
|
4
|
|
ASX - By Stock
|
EMR |
Re:
wow such lows
|
|
NZJim
|
58 |
25K |
3 |
08/07/22 |
08/07/22 |
ASX - By Stock
|
58
|
25K
|
3
|
|
ASX - By Stock
|
TAR |
Re:
Ann: David Chapman Appointed as Non-Executive Director
|
|
NZJim
|
32 |
8.1K |
5 |
11/10/21 |
11/10/21 |
ASX - By Stock
|
32
|
8.1K
|
5
|
|